- Services
- Telehealth
- Diagnostics
- Apps/Software
- Digital Platform
- Consumer Products
- Drugs, Vitamins & Supplements
- Devices (Wearables, Hardware, etc)
Female Health Tech Market size was valued at USD 18,649.2 million in 2023 and is poised to grow at a 16.9% CAGR from 2024 to 2030. Female health tech, also known as femtech, encompasses digital health solutions specifically designed to address women's health needs across various life stages. The market growth is primarily driven by increasing awareness of women's health issues, rising adoption of digital health solutions, and growing investment in women-centric healthcare innovations. Moreover, technological advancements in artificial intelligence, machine learning, and IoT are revolutionizing female health tech. For instance, in March 2023, Ava AG launched an AI-powered fertility tracking wearable that claims to predict ovulation with 90% accuracy. This innovation represents a significant advancement in fertility tracking, potentially improving family planning outcomes and addressing infertility challenges.
However, the female health tech market faces challenges, including data privacy concerns, regulatory hurdles, and the need for clinical validation of emerging technologies. The high cost of some advanced female health tech solutions and limited access in developing regions also hinder market growth. Additionally, the fragmented nature of women's health services and the need for greater integration with existing healthcare systems pose challenges to widespread adoption. Moreover, the female health tech market presents numerous opportunities, particularly in developing regions with growing smartphone penetration and increasing focus on women's health. The development of integrated platforms addressing multiple aspects of women's health, the expansion of telemedicine services, and the rising demand for personalized health solutions offer promising avenues for female health tech market expansion. Current trends in the female health tech market include a focus on mental health and wellness, increasing emphasis on reproductive health beyond fertility, and growing interest in menopause management solutions. The rise of subscription-based models and increasing collaborations between tech companies and healthcare providers are shaping the future of the female health tech market.
Female Health Tech Market Key Developments:
- In September 2023, Elvie, a leading femtech company, secured $97 million in Series C funding to expand its product line and enhance its smart breast pump technology.
- In August 2021, L’Oréal announced a new partnership with Clue, the period-tracking app with 12 million users in 190 countries, and a leader in Femtech, to deepen knowledge of the relationship between skin health and the menstrual cycle. This collaboration bridges L'Oréal's historic skincare expertise and beauty-tech ambitions with Clue’s leadership in reproductive health and data-driven technology.
Female Health Tech Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
16.9%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Female Health Tech Market Dynamics
The female health tech market is primarily driven by the increasing demand for personalized and convenient healthcare solutions among women. The rising prevalence of chronic conditions specific to women, such as polycystic ovary syndrome (PCOS) and endometriosis, is creating a sustained need for effective monitoring and management tools. This trend is further amplified by growing health consciousness and the desire for proactive health management among women globally. Simultaneously, technological innovations are revolutionizing female health tech. The integration of AI and machine learning in menstrual cycle tracking apps has significantly improved prediction accuracy, while advancements in wearable technology are enabling continuous monitoring of various health parameters. These technologies offer the potential for early detection of health issues, improved treatment outcomes, and enhanced overall well-being for women across different life stages.
North-America Got Significant Share of
Female Health Tech Market Regional Analysis
The female health tech market is segmented based on regions as North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. North America female health tech market is expected to dominate, accounting for approximately 45% of the global market share. This leadership position is due to high digital health adoption rates, the strong presence of key femtech players, and favorable reimbursement policies for digital health solutions. Moreover, the Asia-Pacific female health tech market is projected to emerge as the fastest-growing market during the forecast period. This growth is driven by increasing smartphone penetration, rising disposable incomes, and growing awareness of women's health issues in countries like India and China.
Latin America
Europe
Asia Pacific
Middle East
North America
Female Health Tech Market Segmentation
By Product Type
By Indication
- Longevity
- Sexual Health
- Mental Health
- Menopause Care
- Menstrual Health
- General Health Care
- Women’s Wellness
- Pregnancy and Nursing
- Pelvic and Uterine Health Care
- Reproductive Health and Contraception
Frequently Asked Questions
The Female Health Tech Market was valued at USD 18,649.2 million in 2023 and is expected to grow at a 16.9% CAGR from 2024 to 2030.
The Female Health Tech market is segmented based on product type, indication, and geography.
The leading players in the global Female Health Tech market include Flo Health, Inc., Bloomlife, Clue by BioWink GmbH, Ava AG, Elvie, NUVO Inc., and Prelude Fertility, Inc.
Data privacy concerns, regulatory hurdles, and the need for clinical validation of emerging technologies are expected to limit the growth of the female health tech market.
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1.Executive Summary |
| 2.Global Female Health Tech Market Introduction |
| 2.1.Global Female Health Tech Market - Taxonomy |
| 2.2.Global Female Health Tech Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Indication |
| 2.2.3.Region |
| 3.Global Female Health Tech Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Female Health Tech Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Female Health Tech Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Services |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Telehealth |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Diagnostics |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Apps/Software |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Digital Platform |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Consumer Products |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Drugs, Vitamins & Supplements |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Devices (Wearables, Hardware, etc) |
| 5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6.Global Female Health Tech Market By Indication , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Longevity |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Sexual Health |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Mental Health |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Menopause Care |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Menstrual Health |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. General Health Care |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Women’s Wellness |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Pregnancy and Nursing |
| 6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 6.9. Pelvic and Uterine Health Care |
| 6.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.9.3. Market Opportunity Analysis |
| 6.10. Reproductive Health and Contraception |
| 6.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.10.3. Market Opportunity Analysis |
| 7.Global Female Health Tech Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Female Health Tech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Services |
| 8.1.2.Telehealth |
| 8.1.3.Diagnostics |
| 8.1.4.Apps/Software |
| 8.1.5.Digital Platform |
| 8.1.6.Consumer Products |
| 8.1.7.Drugs, Vitamins & Supplements |
| 8.1.8.Devices (Wearables, Hardware, etc) |
| 8.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Longevity |
| 8.2.2.Sexual Health |
| 8.2.3.Mental Health |
| 8.2.4.Menopause Care |
| 8.2.5.Menstrual Health |
| 8.2.6.General Health Care |
| 8.2.7.Women’s Wellness |
| 8.2.8.Pregnancy and Nursing |
| 8.2.9.Pelvic and Uterine Health Care |
| 8.2.10.Reproductive Health and Contraception |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Female Health Tech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Services |
| 9.1.2.Telehealth |
| 9.1.3.Diagnostics |
| 9.1.4.Apps/Software |
| 9.1.5.Digital Platform |
| 9.1.6.Consumer Products |
| 9.1.7.Drugs, Vitamins & Supplements |
| 9.1.8.Devices (Wearables, Hardware, etc) |
| 9.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Longevity |
| 9.2.2.Sexual Health |
| 9.2.3.Mental Health |
| 9.2.4.Menopause Care |
| 9.2.5.Menstrual Health |
| 9.2.6.General Health Care |
| 9.2.7.Women’s Wellness |
| 9.2.8.Pregnancy and Nursing |
| 9.2.9.Pelvic and Uterine Health Care |
| 9.2.10.Reproductive Health and Contraception |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Female Health Tech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Services |
| 10.1.2.Telehealth |
| 10.1.3.Diagnostics |
| 10.1.4.Apps/Software |
| 10.1.5.Digital Platform |
| 10.1.6.Consumer Products |
| 10.1.7.Drugs, Vitamins & Supplements |
| 10.1.8.Devices (Wearables, Hardware, etc) |
| 10.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Longevity |
| 10.2.2.Sexual Health |
| 10.2.3.Mental Health |
| 10.2.4.Menopause Care |
| 10.2.5.Menstrual Health |
| 10.2.6.General Health Care |
| 10.2.7.Women’s Wellness |
| 10.2.8.Pregnancy and Nursing |
| 10.2.9.Pelvic and Uterine Health Care |
| 10.2.10.Reproductive Health and Contraception |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Female Health Tech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Services |
| 11.1.2.Telehealth |
| 11.1.3.Diagnostics |
| 11.1.4.Apps/Software |
| 11.1.5.Digital Platform |
| 11.1.6.Consumer Products |
| 11.1.7.Drugs, Vitamins & Supplements |
| 11.1.8.Devices (Wearables, Hardware, etc) |
| 11.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Longevity |
| 11.2.2.Sexual Health |
| 11.2.3.Mental Health |
| 11.2.4.Menopause Care |
| 11.2.5.Menstrual Health |
| 11.2.6.General Health Care |
| 11.2.7.Women’s Wellness |
| 11.2.8.Pregnancy and Nursing |
| 11.2.9.Pelvic and Uterine Health Care |
| 11.2.10.Reproductive Health and Contraception |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Female Health Tech Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Services |
| 12.1.2.Telehealth |
| 12.1.3.Diagnostics |
| 12.1.4.Apps/Software |
| 12.1.5.Digital Platform |
| 12.1.6.Consumer Products |
| 12.1.7.Drugs, Vitamins & Supplements |
| 12.1.8.Devices (Wearables, Hardware, etc) |
| 12.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Longevity |
| 12.2.2.Sexual Health |
| 12.2.3.Mental Health |
| 12.2.4.Menopause Care |
| 12.2.5.Menstrual Health |
| 12.2.6.General Health Care |
| 12.2.7.Women’s Wellness |
| 12.2.8.Pregnancy and Nursing |
| 12.2.9.Pelvic and Uterine Health Care |
| 12.2.10.Reproductive Health and Contraception |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Flo Health, Inc. |
| 13.2.2.Bloomlife |
| 13.2.3.Clue by BioWink GmbH |
| 13.2.4.Ava AG |
| 13.2.5.Elvie |
| 13.2.6.NUVO Inc. |
| 13.2.7.Prelude Fertility, Inc. |
| 13.2.8.Nurx |
| 13.2.9.Maven Clinic |
| 13.2.10.Glow, Inc. |
| 13.2.11.Progyny, Inc. |
| 13.2.12.Hologic, Inc. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Flo Health, Inc.
- Bloomlife
- Clue by BioWink GmbH
- Ava AG
- Elvie
- NUVO Inc.
- Prelude Fertility, Inc.
- Nurx
- Maven Clinic
- Glow, Inc.
- Progyny, Inc.
- Hologic, Inc.